Navigation Links
Artemis Health Licenses Prenatal Cell-Free DNA Analysis Technology from Stanford University
Date:1/27/2009

About Artemis Health Inc.

Artemis Health Inc. is a privately-held, diagnostics company focused on the development of non-invasive early-pregnancy prenatal tests for use in all pregnant women. Working in collaboration with leading research and clinical institutions, the company has developed cutting-edge technology to transform the field of prenatal testing through the analysis of both whole-cell and cell-free fetal DNA isolated from maternal blood. With a single, maternal blood draw early in pregnancy, Artemis' diagnostic tests will provide women with an accurate alternative to the invasive methods of amniocentesis and chorionic villus sampling available today. For more information about Artemis Health, please visit www.artemishealthinc.com.


'/>"/>
SOURCE Artemis Health Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Exelixis Sells 80% Stake in Artemis to Taconic
2. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
3. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
4. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
7. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
8. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
9. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...FirstCall/-YMBioSciencesInc.(NYSEAmex: YMI ;TSX:YM...fiesandadvancesadiverseportfolioofpromisingcancer-...eportedthatCytopia(ASX:CYT)hascommencedenrollmento...ministeredJAK1/JAK2inhibitor.Thetrialisbeingconduc...rgeCytopiaintoYMhasbeenpreviouslyannouncedandispen...
(Date:11/23/2009)...eDesignC or p.(IDC)announcedtodaythatDr.BruceL.A.C...successfultrackrec or dinbiotechnologyexecutiveman...oGenetics,inSeattle,WAandChiefScientificOfficeratN...p://www.newscom.com/cgi-bin/prnh/20091123/SF15228 ...eOfficercommented,"IamdelightedtowelcomeDr.BruceCa...
(Date:11/23/2009)...ire/--PearlTherapeuticsInc.,abiopharmaceuticalcomp...hronicrespiratorydiseases,todayannouncedtheappoint...Rosenhas25yearsofexperienceinthepharmaceuticalandb...iencesandALZACorporation.Hisappointmentincreasesth...ebringsawealthofproductdevelopment,commercializati...
(Date:11/20/2009)... an opportunity to take the lead in two small biot... of Valencia (UV), working together with the IDICH...of the Spanish biotechnology industry. Their concl...more clout than those in English-speaking countrie... has been overlooked by the leading countries in t...
Breaking Biology Technology:YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Pearl Therapeutics Appoints Howie Rosen to Board of Directors 2Spanish biotechnology should focus on food and plant sectors to be more competitive 2
CELLocate protocol blocks for 55 m microgrid
..., , , , , , With the aid of...c acids , and proteins has established itse... It includes absorption measurements in the ult...teins are measured (directly) at 280 nm, nucleic a...etermination is carried out in the range from , ...
...w System for Improving QPCR , , ...QPCR machines with , the Mx4000 multiplex... offers better performance and functionality at ...e PCR (QPCR) allows researchers to quickly and eas...ression, mutational analysis,disease state, and...
Other Biology Technology:Quantification made easy 2Quantification made easy 3Mx4000 Multiplex Quantitative PCR System*,PPP 2Mx4000 Multiplex Quantitative PCR System*,PPP 3Mx4000 Multiplex Quantitative PCR System*,PPP 4
(Date:11/24/2009)..., Rocket science is opening new doors to understa...affect the hearing of a marine mammal or if they ...ial sized X-ray scanners that NASA uses to detect ...ockets is now allowing scientists to peek inside t...detailed three-dimensional replicas of a whale,s h...
(Date:11/24/2009)..., The atomic-level action of a remarkable class o... researchers with the Lawrence Berkeley National L...protein crystallography beamline at the Advanced L...al roles in gene expression and replication, and a...as well as infectious agents, such as the human pa...
(Date:11/24/2009)..., BATON ROUGE Antarctica has long held secrets...and until recently, there has been very little inf... beneath miles of ice for millions of years. Now, ...uding LSU have been funded to the tune of $10 mil...r NSF, to get to the bottom of things literally. ...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Discovery to aid in future treatments of third world parasites 9371 1Discovery to aid in future treatments of third world parasites 9371 2Heartland Information Services Again Improves in Customer Satisfaction 52818 1Heartland Information Services Again Improves in Customer Satisfaction 52818 2Many Cancer Survivors Dont Adopt Healthy Lifestyle 52815 1Many Cancer Survivors Dont Adopt Healthy Lifestyle 52815 2
...eezing the middle class on land, it,s also affecti...onservation Society (WCS) and other organizations,...etween "middle class" communities in Eastern Afric... low and high socio-economic levels had comparativ... edition of Current Biology , the study examined ...
...terium living 2,500 meters below the ocean,s surfa...e thermal and chemical gradients, according to an ...tics , an open-access publication published by the...d on the bacterium Nautilia profundicola , a micr.... Microorganisms that thrive at these geysers on t...
... The year 2009 marks the 150 anniversary of Charl...minal book that permeated countless disciplines an... the bicentennial anniversary of Darwin,s birth, t...omment on how the Father of Evolution influenced b...y: , Darwin and biology , Franois-Joseph Lapoint...
Other Biology News:Study says 'middle class' coral reef fish feel the economic squeeze 2Genetic adaptations key to microbe's survival in challenging environment 2Darwin's seminal impact on biology, anthropology, philosophy and psychology 2Darwin's seminal impact on biology, anthropology, philosophy and psychology 3Darwin's seminal impact on biology, anthropology, philosophy and psychology 4
Klenow Enzyme; labeling grade, DNA Polymerase I, large fragment from Roche Applied Science
Hexokinase/ Glucose-6-Phosphate Dehydrogenase from Roche Applied Science
Mouse Anti-HLA DQ1, HLA DQ3 Monoclonal Antibody, Unconjugated, Clone HL-37 from Abcam
Pectinase from Sigma-Aldrich
Biology Products: